COSTA, GIULIA
 Distribuzione geografica
Continente #
EU - Europa 79.795
NA - Nord America 3.431
AS - Asia 1.299
SA - Sud America 275
AF - Africa 28
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 84.840
Nazione #
IT - Italia 79.083
US - Stati Uniti d'America 3.366
SG - Singapore 553
CN - Cina 456
BR - Brasile 232
SE - Svezia 203
DE - Germania 121
UA - Ucraina 116
VN - Vietnam 103
GB - Regno Unito 68
FI - Finlandia 62
HK - Hong Kong 42
CA - Canada 41
NL - Olanda 29
FR - Francia 28
KR - Corea 20
JP - Giappone 18
MX - Messico 17
IN - India 15
AR - Argentina 14
PL - Polonia 13
AT - Austria 12
BE - Belgio 12
TR - Turchia 12
BD - Bangladesh 11
ID - Indonesia 11
AE - Emirati Arabi Uniti 10
ES - Italia 9
IQ - Iraq 9
RU - Federazione Russa 9
PE - Perù 8
PK - Pakistan 8
AU - Australia 7
EG - Egitto 7
CZ - Repubblica Ceca 6
CL - Cile 5
EC - Ecuador 5
EU - Europa 5
IL - Israele 5
LT - Lituania 5
MA - Marocco 5
VE - Venezuela 5
ZA - Sudafrica 5
CH - Svizzera 4
IE - Irlanda 4
KE - Kenya 4
MY - Malesia 3
TW - Taiwan 3
BO - Bolivia 2
CO - Colombia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
IR - Iran 2
JO - Giordania 2
NP - Nepal 2
OM - Oman 2
PT - Portogallo 2
SA - Arabia Saudita 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
GR - Grecia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 84.840
Città #
Cagliari 76.843
Uta 2.053
Fairfield 349
Ashburn 320
Chandler 309
Singapore 236
Dallas 184
Woodbridge 184
Ann Arbor 156
Houston 142
Seattle 142
Boardman 133
Wilmington 132
Nyköping 130
Beijing 119
Cambridge 116
New York 75
Dearborn 72
Los Angeles 63
Jacksonville 58
Shanghai 58
Santa Clara 50
Boston 43
The Dalles 40
Helsinki 35
Hong Kong 35
Munich 34
Nanjing 32
Marília 27
Ho Chi Minh City 26
Dong Ket 24
Hefei 24
San Diego 23
Buffalo 21
Hanoi 20
São Paulo 20
Redwood City 17
Seoul 16
Chicago 15
Guangzhou 15
London 15
Rome 15
Tokyo 14
Redondo Beach 12
Toronto 12
Mexico City 11
Norwalk 11
Amsterdam 10
Atlanta 10
Brooklyn 10
Brussels 10
Dubai 10
Shenyang 10
Tianjin 10
Falls Church 9
Frankfurt am Main 9
Phoenix 9
Brasília 8
Nuremberg 8
Stockholm 8
Turku 8
Vienna 8
Changsha 7
Chennai 7
Council Bluffs 7
Düsseldorf 7
Hebei 7
Mountain View 7
Oristano 7
Padova 7
San Jose 7
Shenzhen 7
Warsaw 7
Buenos Aires 6
Curitiba 6
Jinan 6
Lappeenranta 6
Montreal 6
Nanchang 6
San Francisco 6
Washington 6
Chesterton 5
Denver 5
Madrid 5
Orange 5
Orem 5
Rio de Janeiro 5
Sassari 5
Wuhan 5
Almere Stad 4
Berlin 4
Brno 4
Da Nang 4
Haiphong 4
Hangzhou 4
Indiana 4
Istanbul 4
Jakarta 4
Kunming 4
Nanaimo 4
Totale 82.827
Nome #
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.594
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 3.518
The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats 3.132
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms 2.918
Modulation of rat 50-kHz ultrasonic vocalizations by glucocorticoid signaling: possible relevance to reward and motivation 2.788
Methylxanthines and drug dependence: interactions and toxicity 2.665
MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice 2.654
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent 2.609
Neuronal and peripheral damages induced by synthetic psychoactive substances: an update of recent findings from human and animal studies 2.566
Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease 2.499
Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage 2.481
Repeated Administration of 3,4-Methylenedioxymethamphetamine (MDMA) Elevates the Levels of Neuronal Nitric Oxide Synthase in the Nigrostriatal System: Possible Relevance to Neurotoxicity 2.476
Influence of dopamine transmission in the medial prefrontal cortex and dorsal striatum on the emission of 50-kHz ultrasonic vocalizations in rats treated with amphetamine: Effects on drug-stimulated and conditioned calls 2.465
Lack of Rhes Increases MDMA-Induced Neuroinflammation and Dopamine Neuron Degeneration: Role of Gender and Age 2.433
Involvement of Glutamate NMDA Receptors in the Acute, Long-Term, and Conditioned Effects of Amphetamine on Rat 50kHz Ultrasonic Vocalizations 2.405
Activation of adenosine A2A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalizations in rats: possible relevance to reward and motivation 2.381
Rhes counteracts dopamine neuron degeneration and neuroinflammation depending on gender and age 2.359
The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging 2.355
L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies 2.312
MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex 2.227
Emission of categorized 50-kHz ultrasonic vocalizations in rats repeatedly treated with amphetamine or apomorphine: possible relevance to drug-induced modifications in the emotional state 2.084
NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's Disease 1.980
Neurochemical and neurotoxic effects of MDMA (Ecstasy) and caffeine after chronic combined administration in mice 1.927
Neuroinflammation and activation of Zif-268 in dyskinetic 6-OHDA-lesioned rats is counteracted by association of a 5-HT1A/1B receptor agonist and an A2A receptor antagonist 1.799
Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson’s Disease 1.791
Increased emissions of 50-kHz ultrasonic vocalizations in hemiparkinsonian rats repeatedly treated with dopaminomimetic drugs: A potential preclinical model for studying the affective properties of dopamine replacement therapy in Parkinson's disease 1.774
Combined administration of dopaminergic and nondopaminergic drugs reverses neuroinflammation in a rat model of Parkinson’s disease 1.767
Antiparkinsonian actions and interactions of adenosine antagonists 1.601
The small GTP-binding protein Rhes influences midbrain dopaminergic neurons: Behavioral and biochemical studies 1.544
Gender-dependent behavioral and biochemical differences in the A53T genetic mouse model of Parkinson’s disease 1.409
Evaluation of drugs acting on CB1-A2A receptor oligomers in rat models of Parkinson's disease 1.314
In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice 1.083
null 1.005
Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences 935
Withania somnifera influences MDMA-induced hyperthermic, cognitive, neurotoxic and neuroinflammatory effects in mice 927
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists 903
Neurotoxicity of MDMA: Main effects and mechanisms 824
Association between novel object recognition/spontaneous alternation behavior and emission of ultrasonic vocalizations in rats: Possible relevance to the study of memory 820
In vivo antiparkinson activity of drugs acting on A(2A)-CB1-D-2 receptors 792
Involvement of the protein ras homolog enriched in the striatum, rhes, in dopaminergic neurons’ degeneration: Link to parkinson’s disease 769
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 757
Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonist 747
Prenatal and postnatal drug exposure: focus on persistent central effects 707
Fos expression induced by olanzapine and risperidone in the central extended amygdala 705
Vulnerability to cognitive, neurotoxic and neuroinflammatory effects of toxins that induce Parkinson's disease after administration of amphetamine-related drugs in mice 682
The Neuroinflammatory and Neurotoxic Potential of Palmitic Acid Is Mitigated by Oleic Acid in Microglial Cells and Microglial-Neuronal Co-cultures 492
Brain dysfunctions and neurotoxicity induced by psychostimulants in experimental models and humans: an overview of recent findings 441
Divergent acute and enduring changes in 50-kHz ultrasonic vocalizations in rats repeatedly treated with amphetamine and dopaminergic antagonists: new insights on the role of dopamine in calling behavior 297
The hypocretin/orexin system mediates the extinction of fear memories 235
Emission of 50-kHz ultrasonic vocalizations stimulated by antiparkinsonian dopaminomimetic drugs in hemiparkinsonian rats is associated with neuronal activation in subcortical regions that regulate the affective state 131
The administration context does not influence the sensitization in the emission of 50-kHz ultrasonic vocalizations in rats treated with amphetamine in unfamiliar environments: Relevance to drug-induced modifications in the affective state 24
Totale 85.103
Categoria #
all - tutte 105.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.478


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218.047 0 0 0 0 0 2.046 1.313 1.069 568 1.145 1.154 752
2021/20225.539 492 301 283 349 375 389 359 325 426 619 739 882
2022/20239.774 804 1.397 1.055 825 836 1.060 523 554 646 776 869 429
2023/20248.133 314 370 283 418 823 1.332 1.315 625 363 585 852 853
2024/202513.105 2.320 3.251 1.968 1.820 952 1.106 1.052 73 184 121 159 99
2025/20262.120 388 157 421 325 603 226 0 0 0 0 0 0
Totale 85.103